{"id":"W1965717563","doi":"10.1002/cpt.59","title":"From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":187,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux; Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"European Federation of Pharmaceutical Industries and Associations","keywords":"Risk analysis (engineering); Sustainability; Business; Drug development; Life span; Adaptive strategies; New product development; Medicine; Drug; Marketing; Gerontology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006724103,0.000403071,0.001517063,0.0003661944,0.0001695957,0.00008837734,0.0006936673,0.0003392685,0.0001012626],"category_scores_gemma":[0.001067087,0.0005201814,0.0002174058,0.0004667809,0.00008433702,0.0003083477,0.0004171817,0.000559114,0.006494322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009005607,"about_ca_system_score_gemma":0.0005779593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001866378,"about_ca_topic_score_gemma":0.00004172394,"domain_scores_codex":[0.9929453,0.0007391447,0.00399199,0.00128713,0.0001859843,0.0008505005],"domain_scores_gemma":[0.9940641,0.001779321,0.001123616,0.0005508096,0.0003013597,0.002180782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00488686,0.005022421,0.1016945,0.0001089944,0.004277819,0.000008471131,0.1491459,0.05829643,0.0001548703,0.003512714,0.6548702,0.01802076],"study_design_scores_gemma":[0.02048642,0.007213623,0.101101,0.0003989251,0.0006880657,0.000003693475,0.01770869,0.1622939,0.0003316758,0.01089768,0.6743221,0.00455422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8826619,0.0006083203,0.07786708,0.0293936,0.003983655,0.002324432,0.0002986122,0.000180688,0.002681758],"genre_scores_gemma":[0.4670367,0.00006231158,0.06564954,0.4633859,0.003294712,0.00009128523,0.00003293877,0.0001158519,0.000330725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4339923,"threshold_uncertainty_score":0.999725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.696669527203476,"score_gpt":0.5022952081605061,"score_spread":0.1943743190429699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}